Table 1 Patients’ demographic and clinical characteristics.
From: Distinct systemic cytokine networks in symptomatic and asymptomatic carotid stenosis
sCS | aCS | p-value | |
|---|---|---|---|
n = 22 | n = 24 | ||
Age (years), mean ± SD | 66.27 ± 9.44 | 70.54 ± 9.38 | 0.131 |
Sex | 0.066 | ||
Male (%) | 19 (86.4) | 15 (62.5) | |
Female (%) | 3 (13.6) | 9 (37.5) | |
BMI (kg/m2) ± SD | 27.34 ± 3.37 | 29.38 ± 5.74 | 0.155 |
Adiposity (%) | 3 (13.6) | 9 (37.5) | 0.066 |
ESRS on admission (Q1-Q3) | 3 (2–4) | 4 (4–5) | 0.002 |
ESRS at 90 days (Q1-Q3) | 4 (3–4) | 4 (4–5) | 0.083 |
Hypertension (%) | 16 (72.7) | 21 (87.5) | 0.207 |
Diabetes mellitus (%) | 5 (22.7) | 8 (33.3) | 0.425 |
Dyslipoproteinemia (%) | 18 (81.8) | 19 (79.2) | 0.821 |
Peripheral arterial disease (%) | 2 (9.1) | 7 (29.2) | 0.086 |
Nicotine abuse (%) | 17 (77.3) | 19 (79.2) | 0.881 |
Alcohol abuse (%) | 4 (18.2) | 5 (20.8) | 0.821 |
Coronary artery disease (%) | 2 (9.1) | 11 (45.8) | 0.006 |
Previous myocardial infarction (%) | 1 (4.5) | 7 (29.2) | 0.028 |
Atrial fibrillation (%) | 0 (0) | 2 (8.3) | 0.166 |
Previous stroke (%) | 3 (13.6) | 5 (20.8) | 0.520 |
Dementia (%) | 0 (0) | 1 (4.2) | 0.333 |
Epilepsy (%) | 2 (9.1) | 1 (4.2) | 0.499 |
Medication | |||
Antithrombotic pretreatment (%) | 9 (40.9) | 23 (95.8) | < 0.001 |
Statin pretreatment (%) | 8 (36.4) | 18 (75.0) | 0.008 |
NIHSS on admission (Q1–Q3) | 0 (0–2) | N.A | |
NIHSS 90 days (Q1–Q3) | 0 (0–1) | N.A | |
mRS 90 days (Q1–Q3) | 0 (0–1.25) | N.A | |
Grade of stenosis | 0.023 | ||
Moderate | 1 (4.5) | 0 (0) | |
Severe | 10 (45.5) | 20 (83.3) | |
Highly severe | 11 (50.0) | 4 (16.7) | |
Contralateral CS | 13 (59.1) | 8 (33.3) | 0.08 |
Contralateral CO | 1 (4.5) | 3 (12.5) | 0.339 |
Time from ischaemic event to blood collection (days) (Q1–Q3) | 8 (3.5–12) | N.A | |
Time to follow-up (days) (Q1–Q3) | 92 (90–104) | 97 (91–104) | 0.234 |
